Abstract
Purpose of Review
This paper explores how environmental factors influence allergic skin diseases, including atopic dermatitis (AD), contact dermatitis (CD), urticaria, angioedema, and reactions to drugs and insect bites.
Recent Findings
Research indicates a significant impact of environmental elements on allergic skin diseases. High air pollution levels exacerbate symptoms, while climate change contributes to increased skin barrier dysfunction, particularly affecting AD. Allergen prevalence is influenced by climate and pollution. Irritants, like those in detergents and cosmetics, play a major role in CD. Plants also contribute, causing various skin reactions.
Summary
Understanding the interplay between environmental factors and allergic skin diseases is crucial for effective management. Physicians must address these factors to support patient well-being and promote skin health amidst environmental changes.
Similar content being viewed by others
Data Availability
No data was collected or analytical code used as part of this study. All data and information discussed in this article can be found in the articles included on our reference list.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
George S, Yu J. Patch Testing in atopic children: Is there a difference? Curr Dermatol Reports. 2023;12(4):1–6. https://doi.org/10.1007/s13671-023-00409-5.
Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109–22.
Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):209–13.
Bosma AL, et al. Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics. J Eur Acad Dermatol Venereol. 2022;36(6):807–19.
Elias PM, Steinhoff M. “Outside-to-inside” (and now back to “outside”) pathogenic mechanisms in atopic dermatitis. J Invest Dermatol. 2008;128(5):1067–70.
Cork M, et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol. 2003;149(3):582–9.
• Paller AS, et al. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2022;400(10356):908–19.
• Blauvelt A, et al. Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol. 2021;157(9):1047–55.
Mikhaylov D, et al. Oral Janus kinase inhibitors for atopic dermatitis. Ann Allergy Asthma Immunol. 2023;130(5):577–92.
Scheinman PL, et al. Contact dermatitis Nat Rev Dis Primers. 2021;7(1):38.
Diepgen TL, et al. Prevalence of contact allergy in the general population in different European regions. Br J Dermatol. 2016;174(2):319–29.
Alinaghi F, et al. Prevalence of contact allergy in the general population: A systematic review and meta-analysis. Contact Dermatitis. 2019;80(2):77–85.
Li Y, Li L. Contact Dermatitis: Classifications and Management. Clin Rev Allergy Immunol. 2021;61(3):245–81.
Coffin SL, Turrentine JE, Cruz PD Jr. Photodermatitis for the Allergist. Curr Allergy Asthma Rep. 2017;17(6):36.
Kolkhir P, et al. Urticaria Nat Rev Dis Primers. 2022;8(1):61.
Zuberbier T, et al. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol. 2010;35(8):869–73.
Lee SJ, et al. Prevalence and Risk Factors of Urticaria With a Focus on Chronic Urticaria in Children. Allergy Asthma Immunol Res. 2017;9(3):212–9.
Church MK, et al. The role and relevance of mast cells in urticaria. Immunol Rev. 2018;282(1):232–47.
Zuberbier T, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734–66.
Weller K, et al. Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany. J Eur Acad Dermatol Venereol. 2022;36(1):91–9.
Gonçalo M, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021;184(2):226–36.
Türk M, et al. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers. J Allergy Clin Immunol Pract. 2020;8(1):113–24.
Kazandjieva J, Christoff G. Angioedema as a systemic disease. Clin Dermatol. 2019;37(6):636–43.
Zalewska-Janowska A, Spiewak R, Kowalski ML. Cutaneous Manifestation of Drug Allergy and Hypersensitivity. Immunol Allergy Clin North Am. 2017;37(1):165–81.
Naldi L, Crotti S. Epidemiology of cutaneous drug-induced reactions. G Ital Dermatol Venereol. 2014;149(2):207–18.
Ardern-Jones MR, Friedmann PS. Skin manifestations of drug allergy. Br J Clin Pharmacol. 2011;71(5):672–83.
Blumenthal KG, Ziegler JB. Hypersensitivity Reactions, Dietary Supplements, and the Importance of the Case Report. J Allergy Clin Immunol Pract. 2016;4(1):177–8.
Cohen PA. Assessing supplement safety—the FDA’s controversial proposal. N Engl J Med. 2012;366(5):389–91.
Teresa Ventura M, et al. Hypersensitivity reactions to complementary and alternative medicine products. Curr Pharm Des. 2006;12(26):3393–9.
Abrams EM, Golden DBK. Approach to Patients with Stinging Insect Allergy. Med Clin North Am. 2020;104(1):129–43.
Golden DB, et al. Stinging insect hypersensitivity: A practice parameter update 2016. Ann Allergy Asthma Immunol. 2017;118(1):28–54.
Golden DB. Insect sting anaphylaxis. Immunol Allergy Clin North Am. 2007;27(2):261–72.
Simons FER. Anaphylaxis. J Aller Clin Immunol. 2010;125(Supplement 2):S161–81.
Singh S, Mann BK. Insect bite reactions. Indian J Dermatol Venereol Leprol. 2013;79(2):151–64.
Jadoo AS, Treat JR. Caterpillar dermatitis: A brief report. Pediatr Dermatol. 2020;37(3):570–1.
Elston DM. Bites and stings. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. 4th ed. Elsevier; 2018. p. 1516–35.
World Health Organization. WHO global air quality guidelines: particulate matter (PM(2.5) and PM(10)), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide. Geneva: World Health Organization; 2021. https://apps.who.int/iris/bitstream/handle/10665/345329/9789240034228-eng.pdf.
• Li A, et al. Associations between air pollution, climate factors and outpatient visits for eczema in West China Hospital, Chengdu, south-western China: a time series analysis. J Eur Acad Dermatol Venereol. 2018;32(3):486–94.
Pesce G, et al. Adult eczema in Italy: prevalence and associations with environmental factors. J Eur Acad Dermatol Venereol. 2015;29(6):1180–7.
Belugina IN, et al. Outdoor environment, ozone, radionuclide-associated aerosols and incidences of infantile eczema in Minsk. Belarus J Eur Acad Dermatol Venereol. 2018;32(11):1977–85.
Kim YM, et al. Short-term effects of weather and air pollution on atopic dermatitis symptoms in children: A panel study in Korea. PLoS ONE. 2017;12(4): e0175229.
Kim YM, et al. The effects of particulate matter on atopic dermatitis symptoms are influenced by weather type: Application of spatial synoptic classification (SSC). Int J Hyg Environ Health. 2018;221(5):823–9.
Cecchi L, D’Amato G, Annesi-Maesano I. External exposome and allergic respiratory and skin diseases. J Allergy Clin Immunol. 2018;141(3):846–57.
Belzer A, Parker ER. Climate Change, Skin Health, and Dermatologic Disease: A Guide for the Dermatologist. Am J Clin Dermatol. 2023;24(4):577–93.
Andersen LK, et al. Climate change and skin disease: a review of the English-language literature. Int J Dermatol. 2012;51(6):656–61.
St Leger RJ. Insects and their pathogens in a changing climate. J Invertebr Pathol. 2021;184: 107644.
Kuo IH, et al. The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol. 2013;131(2):266–78.
Celebi Sözener Z, et al. Environmental factors in epithelial barrier dysfunction. J Allergy Clin Immunol. 2020;145(6):1517–28.
Román-Carrasco P, et al. The α-Gal Syndrome and Potential Mechanisms. Front Allergy. 2021;2: 783279.
Bains SN, Nash P, Fonacier L. Irritant Contact Dermatitis. Clin Rev Allergy Immunol. 2019;56(1):99–109.
Seyfarth F, et al. Dry skin, barrier function, and irritant contact dermatitis in the elderly. Clin Dermatol. 2011;29(1):31–6.
Zhai H, Maibach HI. Skin occlusion and irritant and allergic contact dermatitis: an overview. Contact Dermatitis: Review Article. 2001;44(4):201–6.
Uter W, Gefeller O, Schwanitz HJ. An epidemiological study of the influence of season (cold and dry air) on the occurrence of irritant skin changes of the hands. Br J Dermatol. 1998;138(2):266–72.
Fluhr J, et al. Additive impairment of the barrier function by mechanical irritation, occlusion and sodium lauryl sulphate in vivo. Br J Dermatol. 2005;153(1):125–31.
McGovern TW. Dermatoses due to plants. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. 4th ed. Elsevier; 2018. p. 286–303.
Williford PM, Sheretz EF. Poison ivy dermatitis. Nuances in treatment Arch Fam Med. 1994;3(2):184–8.
Bousquet J, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012;67(1):18–24.
Nixon RL, et al. Allergic contact dermatitis. In: Bolognia JL, Schaffer JV, Cerroni L, editors., et al., Dermatology. 4th ed. Elsevier; 2018. p. 242–61.
DeKoven JG, et al. North american contact dermatitis group patch test results 2013–2014. Dermatitis. 2017;28(1):33–46.
Zug KA, et al. Patch testing in children from 2005 to 2012: results from the North American contact dermatitis group. Dermatitis. 2014;25(6):345–55.
Jacob SE, Admani S. iPad–increasing nickel exposure in children. Pediatrics. 2014;134(2):e580–2.
Boyapati A, et al. Allergic contact dermatitis to methylisothiazolinone: exposure from baby wipes causing hand dermatitis. Australas J Dermatol. 2013;54(4):264–7.
Scheinman PL. The foul side of fragrance-free products: what every clinician should know about managing patients with fragrance allergy. J Am Acad Dermatol. 1999;41(6):1020–4.
Scheman A, et al. Balsam of Peru: past and future. Dermatitis. 2013;24(4):153–60.
Author information
Authors and Affiliations
Contributions
K.F. wrote the main manuscript text, M.S. revised the manuscript and created informational tables, A.M. provided significant writing guidance/direction and edits. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
Author A declares that she has no conflict of interest. Author B is an Immunovant scientific advisory board consultant, biogen principal investigator for clinical trials, and a Bristol myers squibb principal investigator for clinical trials.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Faraz, K., Seely, M. & Marano, A.L. The role of the environment in allergic skin disease. Curr Allergy Asthma Rep (2024). https://doi.org/10.1007/s11882-024-01147-9
Accepted:
Published:
DOI: https://doi.org/10.1007/s11882-024-01147-9